August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden Statement at Finance Committee Vote on RFK Jr.'s Nomination to be HHS Secretary
- Wyden: Trump Tariffs Will Make Everything More Expensive, Solve Zero Problems and Harm American Farmers and Small Businesses
- Wyden Slams RFK Jr.'s Failure to Answer Basic Questions on Vaccines
- Wyden Demands Answers Following Report of Musk Personnel Seeking Access to Highly Sensitive U.S. Treasury Payments System
- Wyden, Finance Democrats Press RFK Jr. to Reject Big Pharma Pause on Medicare Negotiation